Results 41 to 50 of about 24,579,249 (345)
Медицинская иммунологияThe worldwide circulating influenza viruses annually lead to serious medical and socio-economic consequences. It is generally recognized that vaccination is the most effective and safe strategy for preventing influenza and its complications.
A.-P. S. Shurygina +7 more
doaj +1 more source
Mechanism and suggestions of liver damage caused by influenza A virus: a narrative review [PDF]
Infectious Diseases and Tropical MedicineThis study aimed to explore the causes and mechanisms of liver damage caused by influenza A virus (IAV), compare the liver damage caused by SARS-CoV-2 and IAV under China’s Glasnost, propose treatment and vaccination recommendations for IAV, and provide ...
Y. Yin, R. Luo, S. Li, R. Li
doaj +1 more source
Multicenter clinical evaluation of the Luminex Aries Flu A/B & RSV assay for pediatric and adult respiratory tract specimens [PDF]
, 2017 Influenza A and B viruses and respiratory syncytial virus (RSV) are three common viruses implicated in seasonal respiratory tract infections and are a major cause of morbidity and mortality in adults and children worldwide. In recent years, an increasing
Buller, Richard S +6 more
core +2 more sources
, 2007 The influenza viruses, which contain single-stranded RNA, are classified into 3 types, A, B, and C …
Huggett, Kathryn D., Knoop, Floyd C.
openaire +1 more source
Influenza A virus uncoating [PDF]
, 2020 Influenza A virus (IAV) is an enveloped virus of the Orthomyxoviridae with a negative-sense single-stranded RNA genome. During virus cell entry, viral and cellular cues are delivered in a stepwise manner within two distinct cellular compartments-the endosomes and the cytosol.
openaire +4 more sources
Human Vaccines & Immunotherapeutics, 2020 The rapid evolution of influenza A viruses poses a great challenge to vaccine development. Analytical and machine learning models have been applied to facilitate the process of antigenicity determination.
Eva K. Lee +2 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2022 Influenza A virus (IAV) infections are associated with a high healthcare burden around the world and there is an urgent need to develop more effective therapies.
Joseph Gleason +5 more
doaj +1 more source
Annals of Clinical Microbiology, 2021 배경: STANDARD F Influenza A/B FIA (SD Biosensor Inc, Korea)의 인플루엔자 A 진단능 평가를 위해 Sofia Influenza A+B FIA (Quidel Corp., USA) 와 SD BIOLINE Influenza Ag A/B/A(H1N1) (Standard Diagnostic, Inc., Korea) 와 비교하고자 하였다.방법: 호흡기 바이러스 실시간 RT-PCR이 의뢰된 중복 검체를 제외한 총 ...
수헌 유 +5 more
doaj +1 more source
Influenza vaccination uptake among people aged over 85 years: an audit of primary care practice in the UK [PDF]
, 2014 Public health research and national guidelines have advocated for seasonal influenza vaccination in the elderly. General practice has established itself as an ideal setting for the safe administration and monitoring of vaccines.1 Due to waning immune
Arnott, ND, Fitchett, JR
core +2 more sources
Evolution of Influenza A Virus by Mutation and Re-Assortment
International Journal of Molecular Sciences, 2017 Influenza A virus (IAV), a highly infectious respiratory pathogen, has continued to be a significant threat to global public health. To complete their life cycle, influenza viruses have evolved multiple strategies to interact with a host.
Wenhan Shao +4 more
semanticscholar +1 more source